You have 9 free searches left this month | for more free features.

ILC-P3-PAN

Showing 1 - 25 of 2,163

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial in Seoul (Immuncell-LC, Gemcitabine)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Nov 18, 2021

Advanced Breast Cancer Trial in Puerto Rico, United States (ARV-471, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Coconut Creek, Florida
  • +13 more
Jan 27, 2023

Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Joint Instability Trial in Worldwide (Anterior

Recruiting
  • Anterior Cruciate Ligament Injury
  • +2 more
  • Anterior cruciate ligament reconstruction (ACLR)
  • Lateral extra-articular tenodesis (LET)
  • Redwood City, California
  • +25 more
Dec 19, 2022

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Pneumococcal Infections, Pneumonia, Pneumococcal Trial in United States (Prevnar 13, AFX3772)

Recruiting
  • Pneumococcal Infections
  • Pneumonia, Pneumococcal
  • Prevnar 13
  • AFX3772
  • Jonesboro, Arkansas
  • +31 more
Jan 19, 2023

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Pregnancy, Infants, Disparities Trial in Birmingham (Digital Health intervention, Community Health Worker, Digital Health

    Recruiting
    • Pregnancy
    • +2 more
    • Digital Health intervention
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 14, 2023

    Post-ERCP Acute Pancreatitis Trial in San Francisco, Philadelphia

    Active, not recruiting
    • Post-ERCP Acute Pancreatitis
      • San Francisco, California
      • +1 more
      Jul 22, 2022

      Antigen-specific T Cells in Antisynthetase Syndrome and

      Not yet recruiting
      • Antisynthetase Syndrome
      • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
      • Dijon, France
      • +5 more
      Aug 2, 2023

      Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)

      Terminated
      • Immunity, Innate
      • Colorectal Cancer
      • IVDD for NK cell activity in whole blood
      • Montreal, Quebec, Canada
      • +2 more
      Jan 30, 2023

      Sexually Transmitted Diseases, Safe Sex, Adherence, Medication Trial in United States (P3, P3+, Control)

      Completed
      • Sexually Transmitted Diseases
      • +2 more
      • P3
      • +2 more
      • Tampa, Florida
      • +8 more
      Oct 4, 2022

      Pan Immune Inflammatory Index and Endometriosis

      Active, not recruiting
      • Relationship Between Pan Immune Inflammatory Index and Endometriosis and Endometriosis Stages
        • Ankara, Yenimahalle, Turkey
          Ankara Etlik City Hospital
        Nov 16, 2023

        Type 1 Diabetes, Type 2 Diabetes Trial in Neuss (sotagliflozin (SAR439954))

        Completed
        • Type 1 Diabetes Mellitus
        • Type 2 Diabetes Mellitus
        • sotagliflozin (SAR439954)
        • Neuss, Germany
          Investigational Site Number 276001
        Apr 5, 2022

        Tumors Trial in Beijing ([68Ga]P3)

        Recruiting
        • Neoplasms
        • Beijing, Beijing, China
          Peking University First Hospital
        Jul 4, 2023

        Premature Birth, Decision Making, Prenatal Care Trial in Milwaukee (Preemie Prep for Parents (P3) Outpatient Mobile

        Completed
        • Premature Birth
        • +4 more
        • Preemie Prep for Parents (P3) Outpatient Mobile Intervention
        • ACOG links
        • Milwaukee, Wisconsin
          Froedtert Hospital
        Apr 18, 2022

        Tumors Trial in Beijing ([68Ga]P3)

        Recruiting
        • Neoplasms
        • Beijing, Beijing, China
          Peking University First Hospital
        Jun 4, 2023

        Geriatric Rehabilitation After COVID-19 Disease

        Completed
        • COVID-19
          • Nové Město, Czechia
          • +50 more
          Feb 28, 2023

          Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)

          Not yet recruiting
          • Tumor, Solid
          • RCMI in painting dose on histoscannographic mapping
          • Standard pan-sinusal IMRT
          • Caen, France
          • +2 more
          Jul 5, 2023

          Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

          Recruiting
          • Solid Tumor
          • EGFR Amplification
          • Tianjin, Tianjin, China
            Tianjin Medical University Second Hospital
          Aug 28, 2023

          Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

          Recruiting
          • Solid Tumor
          • +4 more
          • Tianjin, Tianjin, China
            Tianjin Medical University Second Hospital
          Aug 28, 2023

          Prostate Cancer Trial in United States (PAN-301-1)

          Completed
          • Prostate Cancer
          • PAN-301-1
          • Homewood, Alabama
          • +3 more
          Oct 15, 2021

          Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)

          Not yet recruiting
          • Cancer
          • +2 more
          • Pan-genomic Testing
          • Scottsdale, Arizona
          • +2 more
          Aug 18, 2023

          Fungal Infection Trial in Groningen (APX001, Itraconazole, Rifampin)

          Completed
          • Fungal Infection
          • Groningen, Netherlands
            PRA-EDS
          Oct 27, 2021

          Diabetes, Type 2 Trial (Methodological intervention, Toujeo)

          Not yet recruiting
          • Diabetes Mellitus, Type 2
          • Methodological intervention
          • Toujeo
          • (no location specified)
          Mar 21, 2023

          Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

          Recruiting
          • Cancer
          • +2 more
          • Cellworks Report
          • Sioux Falls, South Dakota
            Avera Cancer Institute
          Jan 20, 2023